Tag Archive for: sabizabulin

Weeks after the FDA rejected Veru’s emergency use authorization bid for sabizabulin in COVID-19, the company announced plans to continue with late-stage development of the drug.

Although the agency stated that Veru Inc’s experimental drug for COVID-19 met the main goal of reducing the death rate in a late-stage trial, it flagged a number of uncertainties with the data.